Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
124023623 | 12402362 | 3 | F | 20120802 | 20160608 | 20160525 | 20160715 | EXP | US-GILEAD-2016-0215490 | GILEAD | 12.00 | YR | T | F | Y | 0.00000 | 20160715 | CN | US | US |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
124023623 | 12402362 | 1 | PS | AMBRISENTAN | AMBRISENTAN | 1 | Unknown | 10 MG, QD | 1503901A | 22081 | 10 | MG | TABLET | QD | |||||
124023623 | 12402362 | 2 | SS | REMODULIN | TREPROSTINIL | 1 | Unknown | 91 NG, Q1MINUTE | U | 2100909 | 0 | 91 | NG | /min |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
124023623 | 12402362 | 1 | Pulmonary hypertension |
124023623 | 12402362 | 2 | Pulmonary hypertension |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
124023623 | 12402362 | HO |
124023623 | 12402362 | OT |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
124023623 | 12402362 | Catheter placement | |
124023623 | 12402362 | Device related infection | |
124023623 | 12402362 | Off label use |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|---|
124023623 | 12402362 | 1 | 20120802 | 0 | ||
124023623 | 12402362 | 2 | 20151216 | 0 |